Neurology Medical News about Multiple Sclerosis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study
BMC Neurology, 10/16/09

Sbardella E et al. – The majority of patients with poor clinical response are NAbs negative suggesting that NAbs explains only partially the sub–optimal response to IFNbeta.

<< Previous
Antiphospholipid antibodies and risk of myocardial infarction and...

Next >>
FUS-Immunoreactive Intranuclear Inclusions in Neurodegenerative...

Today in Basic Science/Genetics...keeping you current

Transient Ischemic Attack after Tissue Plasminogen Activator: Aborted Stroke or Unnecessary Stroke Therapy
Cerebrovascular Diseases, 11/10/09

Neonatal seizures and Long QT Syndrome: A cardiocerebral channelopathy
Epilepsia, 11/10/09

Neurological symptoms in patients with biopsy proven celiac disease
Movement Disorders, 11/03/09

See All of Basic Science/Genetics

Today in Demyelinating Disorders...keeping you current

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
The Lancet, 11/03/09

Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Archives of Neurology, 11/11/09

Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure
Journal of Human Hypertension, 11/02/09

See All of Demyelinating Disorders

Today in Neuro/Psych pharmacology...keeping you current

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09

Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09

Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09

See All of Neuro/Psych pharmacology

Sponsor

Article Search